A 24-week Single-blind Trial of Prevention of Hand Eczema in Cleaners (HEIC)

September 9, 2023 updated by: Farnam Barati Sedeh, Zealand University Hospital

Hand Eczema in Cleaners: a Randomized Clinical Trial of Picture-based Prevention Compared to Treatment as Usual Among Professional Hospital Cleaners

This study aims to investigate the effectiveness of picture-based prevention education among professional hospital cleaners in relation to hand eczema. This is a single-blinded randomized clinical trial including hospital cleaners at three different hospitals.

Study Overview

Study Type

Interventional

Enrollment (Actual)

234

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Zealand Region
      • Køge, Zealand Region, Denmark
        • Cleaning departments at Køge, Slagelse and Holbæk hospitals

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Professional hospital cleaners ≥ 18 years old
  • Sufficient Danish skills
  • Written informed consent

Exclusion Criteria:

  • Insufficient Danish skills
  • Pregnancy
  • Other skin diseases on the hands
  • Receiving Immunomodulatory therapies

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Group 1: Picture-based prevention education and an educational course
The participants will have access to picture-based prevention education, and at the same time, they will participate in an educational course.
Assessed by the self-reported cases of newly-developed hand eczema. Change between baseline and 6 months.
Assessed by using the Hand Eczema Severity Index (HECSI). HECSI score: 0-360 points (0 best, 360 worst). Change between baseline and 6 months.
Self-reported total number of sick days due to having hand eczema. Change between baseline and 6 months.
Self-reported change of job due to having hand eczema. Change between baseline and 6 months.
Assessed by using Hand Eczema Questionnaire (QolHEQ). Change between baseline and 6 months.
Self-reported level of knowledge regarding skin care and protection. Change between baseline and 6 months.
Experimental: Group 2: Picture-based prevention education only (no educational course)
The participants will only have access to picture-based prevention education and will not participate in any educational course.
Assessed by the self-reported cases of newly-developed hand eczema. Change between baseline and 6 months.
Assessed by using the Hand Eczema Severity Index (HECSI). HECSI score: 0-360 points (0 best, 360 worst). Change between baseline and 6 months.
Self-reported total number of sick days due to having hand eczema. Change between baseline and 6 months.
Self-reported change of job due to having hand eczema. Change between baseline and 6 months.
Assessed by using Hand Eczema Questionnaire (QolHEQ). Change between baseline and 6 months.
Self-reported level of knowledge regarding skin care and protection. Change between baseline and 6 months.
Placebo Comparator: Group 3: Placebo (control)
The participants will not have access to picture-based prevention education and do not participate in any educational course.
Assessed by the self-reported cases of newly-developed hand eczema. Change between baseline and 6 months.
Assessed by using the Hand Eczema Severity Index (HECSI). HECSI score: 0-360 points (0 best, 360 worst). Change between baseline and 6 months.
Self-reported total number of sick days due to having hand eczema. Change between baseline and 6 months.
Self-reported change of job due to having hand eczema. Change between baseline and 6 months.
Assessed by using Hand Eczema Questionnaire (QolHEQ). Change between baseline and 6 months.
Self-reported level of knowledge regarding skin care and protection. Change between baseline and 6 months.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Incidence rate of hand eczema
Time Frame: Change between baseline and 6 months
Measured by a self-reported questionnaire
Change between baseline and 6 months
Hand Eczema Severity Index (HECSI)
Time Frame: Change between baseline and 6 months
Objective assessment of disease severity, measured by HECSI-score: 0-360 points (0 best, 360) worst)
Change between baseline and 6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Rate of absence from work due to having hand eczema
Time Frame: Change between baseline and 6 months
Measured by a self-reported questionnaire
Change between baseline and 6 months
Rate of participants being forced to change their job due to having hand eczema (questionnaire-based).
Time Frame: Change between baseline and 6 months
Measured by a self-reported questionnaire
Change between baseline and 6 months
The Quality Of Life in Hand Eczema Questionnaire (QqlHEQ)
Time Frame: Change between baseline and 6 months
Subjective assessment of quality of life using QqlHEQ which contains 30 items; generally, all items are scored 0-4 (only three items differ in their scoring structure).
Change between baseline and 6 months
Rate of knowledge regarding skin care and protection.
Time Frame: Change between baseline and 6 months
Measured by a self-reported questionnaire
Change between baseline and 6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Kristina Sophie Ibler, M.D., Zealand University Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 14, 2022

Primary Completion (Actual)

June 24, 2023

Study Completion (Actual)

June 24, 2023

Study Registration Dates

First Submitted

February 14, 2023

First Submitted That Met QC Criteria

March 8, 2023

First Posted (Actual)

March 10, 2023

Study Record Updates

Last Update Posted (Actual)

September 13, 2023

Last Update Submitted That Met QC Criteria

September 9, 2023

Last Verified

September 1, 2023

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 20205100702

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

The results of the project will be shared with other researchers.

IPD Sharing Time Frame

Materials will be made available six months after the publication of the primary outcomes.

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP
  • ICF

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hand Eczema

Clinical Trials on Change in the incidence of hand eczema

Subscribe